DX Revenue and Competitors

Iver, UK

Location

N/A

Total Funding

Logistics

Industry

Estimated Revenue & Valuation

  • DX's estimated annual revenue is currently $855.7M per year.(i)
  • DX's estimated revenue per employee is $427,000

Employee Data

  • DX has 2004 Employees.(i)
  • DX grew their employee count by 6% last year.

DX's People

NameTitleEmail/Phone
1
Head Operational FinanceReveal Email/Phone
2
Head International ServicesReveal Email/Phone
3
Head Information SecurityReveal Email/Phone
4
Head CommercialReveal Email/Phone
5
Head Customer CareReveal Email/Phone
6
Head Document Exchange (North)Reveal Email/Phone
7
Head Customer Experience 2-ManReveal Email/Phone
8
Head Management ServicesReveal Email/Phone
9
Head Account Management for DX Freight 1-ManReveal Email/Phone
10
Account DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$23.8M7824%N/AN/A
#2
$1.2M8-20%N/AN/A
#3
$2.6M14-30%N/AN/A
#4
$206.3M5412%N/AN/A
#5
$456M10685%N/AN/A
#6
$436M10217%N/AN/A
#7
$159.7M4198%N/AN/A
#8
$247.8M6508%N/AN/A
#9
$165.5M4347%N/AN/A
#10
$260M68220%N/AN/A
Add Company

What Is DX?

DX, established in 1975, is a leading independent mail, parcels and logistics end to end network operator in the UK and Ireland (Eire).\r\n\r\nWe provide proven next day delivery services for mail, parcels and 2-Man deliveries to both business and residential addresses, for public and private sector companies. In particular, we specialise in next day or scheduled delivery of time sensitive, mission critical and high value items for B2B and B2C customers. \r\n\r\nWe routinely handle goods from etailers, high street retailers including home ware, and a wide range of items from many industry sectors including legal, optical, pharmaceutical, construction, manufacturing and high street fashion. In fact, no matter the shape or size, we can deliver it!

keywords:N/A

N/A

Total Funding

2004

Number of Employees

$855.7M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

DX News

2022-04-20 - Updated ASCO Guidelines Strongly Recommend Use of the ...

Postmenopausal women with Oncotype DX Breast Recurrence Score® results of 0 to 25 did not show benefit from the addition of chemotherapy to...

2022-04-19 - Dynex Capital, Inc. (DX) CEO Byron Boston on Q1 2022 Results - Earnings Call Transcript

Dynex Capital, Inc. (NYSE:DX) Q1 2022 Earnings Conference Call April 27, 2022 10:00 AM ET. Company Participants. Alison Griffin - VP, IR.